DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
du Bois A, Combe M, Rochon J. et al.
Epirubicin/paclitaxel/carboplatin (TEC) vs. paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer (OC) FIGO stages IIB-IV. An AGO-GINECO Intergroup phase III trial.
J Clin Oncol 2004; 22: 5007-5007
We do not assume any responsibility for the contents of the web pages of other providers.